142 related articles for article (PubMed ID: 21851867)
1. Erythropoietin stimulates bone formation, cell proliferation, and angiogenesis in a femoral segmental defect model in mice.
Holstein JH; Orth M; Scheuer C; Tami A; Becker SC; Garcia P; Histing T; Mörsdorf P; Klein M; Pohlemann T; Menger MD
Bone; 2011 Nov; 49(5):1037-45. PubMed ID: 21851867
[TBL] [Abstract][Full Text] [Related]
2. Expression of VEGF gene isoforms in a rat segmental bone defect model treated with EPCs.
Li R; Nauth A; Li C; Qamirani E; Atesok K; Schemitsch EH
J Orthop Trauma; 2012 Dec; 26(12):689-92. PubMed ID: 22932749
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin protects critically perfused flap tissue.
Rezaeian F; Wettstein R; Amon M; Scheuer C; Schramm R; Menger MD; Pittet B; Harder Y
Ann Surg; 2008 Dec; 248(6):919-29. PubMed ID: 19092336
[TBL] [Abstract][Full Text] [Related]
4. Effect of cell-based VEGF gene therapy on healing of a segmental bone defect.
Li R; Stewart DJ; von Schroeder HP; Mackinnon ES; Schemitsch EH
J Orthop Res; 2009 Jan; 27(1):8-14. PubMed ID: 18634016
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin (EPO): EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing.
Holstein JH; Menger MD; Scheuer C; Meier C; Culemann U; Wirbel RJ; Garcia P; Pohlemann T
Life Sci; 2007 Feb; 80(10):893-900. PubMed ID: 17161437
[TBL] [Abstract][Full Text] [Related]
6. Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: A drill-hole defect model.
He YX; Zhang G; Pan XH; Liu Z; Zheng LZ; Chan CW; Lee KM; Cao YP; Li G; Wei L; Hung LK; Leung KS; Qin L
Bone; 2011 Jun; 48(6):1388-400. PubMed ID: 21421090
[TBL] [Abstract][Full Text] [Related]
7. Preoperative administration of erythropoietin stimulates tumor recurrence after surgical excision of colon cancer in mice by a vascular endothelial growth factor-independent mechanism.
Pascual M; Bohle B; Alonso S; Mayol X; Salvans S; Grande L; Pera M
J Surg Res; 2013 Jul; 183(1):270-7. PubMed ID: 23348072
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of VEGF in subchondral bone of necrotic femoral heads in rabbits with use of extracorporeal shock waves.
Ma HZ; Zeng BF; Li XL
Calcif Tissue Int; 2007 Aug; 81(2):124-31. PubMed ID: 17629736
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the osteogenesis and angiogenesis effects of erythropoietin and the efficacy of deproteinized bovine bone/recombinant human erythropoietin scaffold on bone defect repair.
Li D; Deng L; Xie X; Yang Z; Kang P
J Mater Sci Mater Med; 2016 Jun; 27(6):101. PubMed ID: 27091043
[TBL] [Abstract][Full Text] [Related]
10. EPO reverses defective wound repair in hypercholesterolaemic mice by increasing functional angiogenesis.
Elsherbiny A; Högger DC; Borozadi MK; Schmidt CA; Plock J; Largo RD; Lindenblatt N; Giovanoli P; Contaldo C
J Plast Reconstr Aesthet Surg; 2012 Nov; 65(11):1559-68. PubMed ID: 22704605
[TBL] [Abstract][Full Text] [Related]
11. The role of erythropoietin in regulating angiogenesis.
Kertesz N; Wu J; Chen TH; Sucov HM; Wu H
Dev Biol; 2004 Dec; 276(1):101-10. PubMed ID: 15531367
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues.
Tarkka T; Sipola A; Jämsä T; Soini Y; Ylä-Herttuala S; Tuukkanen J; Hautala T
J Gene Med; 2003 Jul; 5(7):560-6. PubMed ID: 12825195
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells.
Zwezdaryk KJ; Coffelt SB; Figueroa YG; Liu J; Phinney DG; LaMarca HL; Florez L; Morris CB; Hoyle GW; Scandurro AB
Exp Hematol; 2007 Apr; 35(4):640-52. PubMed ID: 17379074
[TBL] [Abstract][Full Text] [Related]
14. Increased VEGF expression in the epiphyseal cartilage after ischemic necrosis of the capital femoral epiphysis.
Kim HK; Bian H; Randall T; Garces A; Gerstenfeld LC; Einhorn TA
J Bone Miner Res; 2004 Dec; 19(12):2041-8. PubMed ID: 15537448
[TBL] [Abstract][Full Text] [Related]
15. Endothelial progenitor cells promote fracture healing in a segmental bone defect model.
Atesok K; Li R; Stewart DJ; Schemitsch EH
J Orthop Res; 2010 Aug; 28(8):1007-14. PubMed ID: 20135674
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin does not improve fracture healing in aged mice.
Orth M; Baudach J; Scheuer C; Osche D; Veith NT; Braun BJ; Rollmann MF; Herath SC; Pohlemann T; Menger MD; Histing T
Exp Gerontol; 2019 Jul; 122():1-9. PubMed ID: 30998964
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects.
Geiger F; Bertram H; Berger I; Lorenz H; Wall O; Eckhardt C; Simank HG; Richter W
J Bone Miner Res; 2005 Nov; 20(11):2028-35. PubMed ID: 16234976
[TBL] [Abstract][Full Text] [Related]
19. Administration of erythropoietin prevents bone loss in osteonecrosis of the femoral head in mice.
Xu T; Jin H; Lao Y; Wang P; Zhang S; Ruan H; Mao Q; Zhou L; Xiao L; Tong P; Wu C
Mol Med Rep; 2017 Dec; 16(6):8755-8762. PubMed ID: 29039481
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.
Li Y; Lu Z; Keogh CL; Yu SP; Wei L
J Cereb Blood Flow Metab; 2007 May; 27(5):1043-54. PubMed ID: 17077815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
